Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 4450
Single User License Price INR 306605
Corporate User License Price USD 6250
Corporate User License Price INR 430625
Request a Quote

Report Title

Global Sleeping Bruxism Treatment Market Research Report - Forecast to 2023

Quote Request for License Type
License Type Price  
Single User License USD 4450
Enterprise Wide License USD 6250
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Global Sleeping Bruxism Treatment Market Research Report - Forecast to 2023


Quote Request for License Type
License Type Price  
Single User License USD 4450
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Global Sleeping Bruxism Treatment Market Research Report - Forecast to 2023

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Global Sleeping Bruxism Treatment Market Research Report - Forecast to 2023



Executive Summary

Introduction

Sleep bruxism or nocturnal tooth grinding is a medical condition indicated by the clenching or grinding of teeth during sleep. The global sleeping bruxism treatment market is estimated to be driven by the increasing prevalence of sleep bruxism, growth in child population, changing lifestyle, and rising prevalence of obstructive sleep apnea. Sleep bruxism is a sleep-related movement disorder, characterized by teeth grinding and jaw clenching during sleep. Since the past few years, it has been reported that the prevalence of the disease has increased. According to a study published by the Sleep Research Society, the general prevalence of sleep bruxism was estimated to range from 5.0 to 8.0% in 2016. In the presence of such trends, the reported cases of headaches and tooth wear due to sleep bruxism are estimated to increase, thereby, mounting a negative impact on patients' lives. Few effective ways to avoid such complications associated with the disease include the administration of medication, antidepressants, and muscle relaxants and wearing a mouth guard, besides others. Thus, it is estimated that the increasing prevalence of sleep bruxism is subsequently increasing the demand for available therapeutic options involving antidepressants, muscle relaxants, and mouth guard, besides others. Conclusively, it is expected to provide favorable backgrounds for the market to grow during the forecast period.

However, factors such as the limited availability of treatment options and the high cost of custom fit night guards restrain the market growth. There is no specific cure, i.e., medications are not very effective for the treatment of sleep bruxism. In such circumstances, it becomes important to manage the consequences of the disorder by available preventative measures, which involves the application of mandibular advancement devices, occlusal splints, stress management, drugs, occlusal splints, and others. A variety of medications such as anti-anxiety drugs and muscle relaxants are significantly employed in the treatment of sleep bruxism. However, it is reported that such medication options come with the capping of side effects such as constipation, nausea, and muscle weakness, amongst others. Following the same course, it is evident that bruxism mouth-guards ground down with time during bruxism episodes. Thus, it is estimated that available treatment options are not effective and incorporate side effects, making the patients reluctant to opt for available treatment options. This makes the market to lag during the study.

 

The global sleeping bruxism treatment market is estimated to reach USD 168.74 million by 2023, from USD 118.02 million in 2017. The market is projected to register a CAGR of 6.1%, during the forecast period from 2018 to 2023.

The sleeping bruxism treatment market comprises a variety of products. Based on the treatment type, the global market for sleeping bruxism treatments is segmented into primary bruxism and secondary bruxism. In primary bruxism, the chewing muscle activity and the autonomic nervous system is triggered by sleep arousals that eventually lead to teeth grinding. The primary bruxism segment held the largest market share and is estimated to reach USD 168.74 million by 2023 from USD 118.02 million in 2017.

The global sleeping bruxism treatment market is segmented into diagnosis types which are inclusive of clinical examination, electromyographic methods, polysomnography, x-ray, and others.

Based on treatment, the global sleeping bruxism treatment market is segmented into dental approaches and medication. Dental approaches are the first line treatment given to the patients of sleeping bruxism and include splints and mouth guards. Thus, dental approaches account for the largest market share.

Based on the cause, the global sleeping bruxism treatment market is segmented into obstructive sleep apnea, sleep paralysis, Gastro-Esophageal Reflux Disease (GERD) malocclusion, and others. Obstructive sleep apnea is a sleep disorder that is characterized by repetitive breathing interruption in sleep. According to the National Sleep Foundation, one in four people with obstructive sleep apnea, clench their teeth in sleep. Thus, obstructive sleep apnea is one of the major causes of sleeping bruxism and held the largest segment in 2017.

Based on its patient type, the global sleeping bruxism treatment market is segmented into pediatric and adult. Sleep bruxism occurs in children when they are taking a sound sleep and are under stress. Anger and nervousness lead to bruxism in kids. According to KidsHealth, three out of every ten children suffer from sleep bruxism. Hence, the pediatric segment is estimated to hold the largest market share during the forecast period.

On the basis of end-user, the global sleeping bruxism treatment market is segmented into hospitals, dental clinics, and others. Dental clinics offer mouth guards, splints, orthodontic treatment and dental corrections. The increased use of dental approaches for teeth restoration accounts for a major market share of the sleep bruxism treatment market.

Key Players

The key players for the sleeping bruxism treatment market include Randmark Dental Products, LLC, S4S Dental Laboratory, Ipsen Biopharmaceuticals, Inc, Merz Pharma GmbH & Co. KGaA, Carestream Dental, PLANMECA OY, and others.

Study Objectives

To provide historical and forecast revenue of market segments and sub-segments with respect to regional markets and their countries

To provide insights into factors influencing and affecting the market growth

To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market

To provide economic factors that influence the global sleeping bruxism treatment market

 

Target Audience

Pharmaceutical and Medical Device Industries

Potential Investors

Medical Research Institutes

Key Executives (CEO and COO) and Strategy Growth Managers

Research Companies

Key Findings

The major market players in the global sleeping bruxism treatment market are Randmark Dental Products, LLC, S4S Dental Laboratory, and Ipsen Biopharmaceuticals, Inc

 

Based on type, the primary bruxism segment held the largest market share and is estimated to reach USD 168.74 million by 2023 from USD 118.02 million in 2017.

On the basis of treatment type, dental approaches account for the largest market share and are estimated to register a CAGR of 7.0% from 2018 to 2023

 

Based on cause, the obstructive sleep apnea market is projected to reach USD 233.20 million by the end of 2023.

 

 

The report also covers regional analysis

Americas

North America

o US

o Canada

South America

Europe

Western Europe

o Germany

o France

o UK

o Scandinavia

? Denmark

? Norway

? Sweden

? Finland

? Iceland

o Benelux Union

? Belgium

? Netherlands

? Luxembourg

o Italy

o Spain

o Switzerland

Eastern Europe

Asia-Pacific

o China

o India

o Japan

o South Korea

o Rest of the Asia-Pacific

Middle East & Africa

Middle East

Africa

Table of Contents:

 

1 Report Prologue

2 Market Introduction

2.1 Introduction

2.2 Assumptions & Limitations

3 Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Data Triangulation

4 Market Dynamics

4.1 Introduction

4.2 Drivers

4.2.1 Increasing prevalence of sleep bruxism

4.2.2 Growing child population

4.2.3 Rising prevalence of obstructive sleep apnea

4.2.4 Lifestyle changes

4.2.5 Drivers Impact Analysis

4.3 Restraints

4.3.1 Limited availability of treatment options

4.3.2 High cost of custom fit night guards

4.3.3 Restraints Impact Analysis

4.4 Opportunity

4.4.1 Untapped markets of the Asia Pacific region

4.5 Macroeconomic Indicator

5 Market Factor Analysis

5.1 Value Chain Analysis

5.1.1 R&D and Designing

5.1.2 Manufacturing

5.1.3 Distribution & Sales

5.1.4 Post-Sales Review

?

5.2 Porter's Five Forces Model

5.2.1 Bargaining Power of Suppliers

5.2.2 Bargaining Power of Buyers

5.2.3 Threat of New Entrants

5.2.4 Threat of Substitutes

5.2.5 Intensity of Rivalry

5.3 Investment Opportunities

5.4 Pricing Analysis

6 Global Sleeping Bruxism Treatment Market, by Type

6.1 Introduction

6.2 Primary Bruxism

6.3 Secondary Bruxism

7 Global Sleeping Bruxism Treatment Market, by Diagnosis

7.1 Introduction

7.1.1 Clinical Examination

7.1.2 X-rays

7.1.3 Electromyographic Methods

7.1.4 Polysomnography

8 Global Sleeping Bruxism Treatment Market, by Treatment Type

8.1 Introduction

8.2 Dental Approaches

8.3 Medication

9 Global Sleeping Bruxism Treatment Market, by Cause

9.1 Introduction

9.2 Obstructive Sleep Apnea

9.3 Gastroesophageal reflux disease (GERD)

9.4 Malocclusion

9.5 Sleep Paralysis

10 Global Sleeping Bruxism Treatment Market, by Patient Type

10.1 Introduction

10.2 Pediatric

10.3 Adult

11 Global Sleeping Bruxism Treatment Market, by End-User

11.1 Introduction

11.2 Hospitals

11.3 Dental Clinics

12 Global Sleeping Bruxism Treatment Market, by Region

12.1 Introduction

12.2 Americas

12.2.1 North America

12.2.1.1 US

12.2.1.2 Canada

12.2.2 South America

12.3 Europe

12.3.1 Introduction

12.3.2 Western Europe

12.3.2.1 Germany

12.3.2.2 France

12.3.2.3 U.K

12.3.2.4 Scandinavia

12.3.2.4.1 Denmark

12.3.2.4.2 Norway

12.3.2.4.3 Sweden

12.3.2.4.4 Finland

12.3.2.4.5 Iceland

12.3.2.5 Benelux Union

12.3.2.5.1 Belgium

12.3.2.5.2 Netherlands

12.3.2.5.3 Luxembourg

12.3.2.6 Italy

12.3.2.7 Spain

12.3.2.8 Switzerland

12.3.3 Eastern Europe

12.4 Asia Pacific

12.4.1 Introduction

12.4.2 China

12.4.3 India

12.4.4 Japan

12.4.5 South Korea

12.4.6 Rest of Asia Pacific

12.5 Middle East & Africa

12.5.1 Introduction

12.5.2 Middle East

12.5.3 Africa

13 Competitive Analysis

13.1 Introduction

14 Company Profiles

14.1 Ivoclar Vivadent AG

14.1.1 Company Overview

14.1.2 Financial Overview

14.1.3 Products Offering

14.1.4 Key Developments

14.1.5 SWOT Analysis

14.1.6 Key Strategy

14.2 Ipsen Biopharmaceuticals, Inc.

14.2.1 Company Overview

14.2.2 Financial Overview

14.2.3 Products Offering

14.2.4 Key Developments

14.2.5 SWOT Analysis

14.2.6 Key Strategy

14.3 Merz Pharma GmbH & Co. KGaA

14.3.1 Company Overview

14.3.2 Financial Overview

14.3.3 Products Offering

14.3.4 Key Developments

14.3.5 SWOT Analysis

14.3.6 Key Strategy

14.4 Carestream Dental

14.4.1 Company Overview

14.4.2 Financial Overview

14.4.3 Products Offering

14.4.4 Key Developments

14.4.5 SWOT Analysis

14.4.6 Key Strategy

14.5 Akervall Technologies Inc.

14.5.1 Company Overview

14.5.2 Financial Overview

14.5.3 Products Offering

14.5.4 Key Developments

14.5.5 SWOT Analysis

14.5.6 Key Strategy

14.6 PLANMECA OY

14.6.1 Company Overview

14.6.2 Financial Overview

14.6.3 Products Offering

14.6.4 Key Developments

14.6.5 SWOT Analysis

14.6.6 Key Strategy

14.7 Randmark Dental Products, LLC

14.7.1 Company Overview

14.7.2 Financial Overview

14.7.3 Products Offering

14.7.4 Key Developments

14.7.5 SWOT Analysis

14.7.6 Key Strategy

14.8 S4S Dental Laboratory

14.8.1 Company Overview

14.8.2 Financial Overview

14.8.3 Products Offering

14.8.4 Key Developments

14.8.5 SWOT Analysis

14.8.6 Key Strategy

14.9 Patterson Dental Supply, Inc.

14.9.1 Company Overview

14.9.2 Financial Overview

14.9.3 Products Offering

14.9.4 Key Developments

14.9.5 SWOT Analysis

14.9.6 Key Strategy

14.1 Henry Schein, Inc.

14.10.1 Company Overview

14.10.2 Financial Overview

14.10.3 Products Offering

14.10.4 Key Developments

14.10.5 SWOT Analysis

14.10.6 Key Strategy

14.11 Pfizer Inc.

14.11.1 Company Overview

14.11.2 Financial Overview

14.11.3 Products Offering

14.11.4 Key Developments

14.11.5 SWOT Analysis

14.11.6 Key Strategy

15 Appendix

15.1 Discussion Blue Print

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures:

 

FIGURE 1 MARKET STRUCTURE

FIGURE 2 RESEARCH PROCESS

FIGURE 3 DROC ANALYSIS OF THE GLOBAL SLEEPING BRUXISM TREATMENT MARKET

FIGURE 4 DRIVERS IMPACT ANALYSIS: GLOBAL SLEEPING BRUXISM TREATMENT MARKET

FIGURE 5 RESTRAINTS IMPACT ANALYSIS: GLOBAL SLEEPING BRUXISM TREATMENT MARKET

FIGURE 6 VALUE CHAIN: GLOBAL SLEEPING BRUXISM TREATMENT MARKET

FIGURE 7 PORTER'S FIVE FORCES MODEL: GLOBAL SLEEPING BRUXISM TREATMENT MARKET

FIGURE 8 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2017 & 2023

FIGURE 9 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT TYPE 2017 & 2023

FIGURE 10 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2017 & 2023

FIGURE 11 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2017 & 2023

FIGURE 12 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2017 & 2023

FIGURE 13 GLOBAL SLEEPING BRUXISM TREATMENT MARKET SHARE BY REGION 2017 (%)

FIGURE 14 AMERICAS SLEEPING BRUXISM TREATMENT MARKET SHARE BY REGION 2017 (%)

FIGURE 15 EUROPE SLEEPING BRUXISM TREATMENT MARKET SHARE BY REGION 2017 (%)

List of Tables:

 

TABLE 1 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 2 GLOBAL SLEEPING BRUXISM TREATMENT MARKET FOR PRIMARY BRUXISM 2015-2023 (USD MILLION)

TABLE 3 GLOBAL SLEEPING BRUXISM TREATMENT MARKET FOR SECONDARY BRUXISM 2015-2023 (USD MILLION)

TABLE 4 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 5 GLOBAL SLEEPING BRUXISM TREATMENT MARKET FOR DENTAL APPROACHES 2015-2023 (USD MILLION)

TABLE 6 GLOBAL SLEEPING BRUXISM TREATMENT MARKET FOR MEDICATION 2015-2023 (USD MILLION)

TABLE 7 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 8 GLOBAL SLEEPING BRUXISM TREATMENT MARKET FOR OBSTRUCTIVE SLEEP APNEA 2015-2023 (USD MILLION)

TABLE 9 GLOBAL SLEEPING BRUXISM TREATMENT MARKET FOR GASTROESOPHAGEAL REFLUX DISEASE (GERD) 2015-2023 (USD MILLION)

TABLE 10 GLOBAL SLEEPING BRUXISM TREATMENT MARKET FOR MALOCCLUSION 2015-2023 (USD MILLION)

TABLE 11 GLOBAL SLEEPING BRUXISM TREATMENT MARKET FOR SLEEP PARALYSIS 2015-2023 (USD MILLION)

TABLE 12 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 13 GLOBAL SLEEPING BRUXISM TREATMENT MARKET FOR PEDIATRIC 2015-2023 (USD MILLION)

TABLE 14 GLOBAL SLEEPING BRUXISM TREATMENT MARKET FOR ADULT 2015-2023 (USD MILLION)

TABLE 15 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 16 GLOBAL SLEEPING BRUXISM TREATMENT MARKET FOR HOSPITALS 2015-2023 (USD MILLION)

TABLE 17 GLOBAL SLEEPING BRUXISM TREATMENT MARKET FOR DENTAL CLINICS 2015-2023 (USD MILLION)

TABLE 18 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 19 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 20 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 21 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 22 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 23 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 24 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 25 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 26 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 27 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 28 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 29 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 30 U.S SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 31 U.S SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 32 U.S SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 33 U.S SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 34 U.S SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 35 CANADA SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 36 CANADA SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 37 CANADA SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 38 CANADA SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 39 CANADA SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 40 SOUTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION).

TABLE 41 SOUTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 42 SOUTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 43 SOUTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 44 SOUTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 45 EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 46 EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 47 EUROPE SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 48 EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 49 EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 50 EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 51 WESTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 52 WESTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 53 WESTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 54 WESTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 55 WESTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 56 GERMANY SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 57 GERMANY SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 58 GERMANY SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 59 GERMANY SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 60 GERMANY SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 61 FRANCE SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 62 FRANCE SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 63 FRANCE SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 64 FRANCE SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 65 FRANCE SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 66 U.K SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 67 U.K SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 68 U.K SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 69 U.K SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 70 U.K SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 71 SCANDINAVIA SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 72 SCANDINAVIA SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 73 SCANDINAVIA SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 74 SCANDINAVIA SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 75 SCANDINAVIA SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 76 DENMARK SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 77 DENMARK SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 78 DENMARK SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 79 DENMARK SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 80 DENMARK SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 81 NORWAY SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 82 NORWAY SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 83 NORWAY SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 84 NORWAY SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 85 NORWAY SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 86 SWEDEN SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 87 SWEDEN SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 88 SWEDEN SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 89 SWEDEN SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 90 SWEDEN SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 91 FINLAND SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 92 FINLAND SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 93 FINLAND SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 94 FINLAND SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 95 FINLAND SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 96 ICELAND SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 97 ICELAND SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 98 ICELAND SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 99 ICELAND SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 100 ICELAND SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 101 BENELUX UNION SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 102 BENELUX UNION SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 103 BENELUX UNION SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 104 BENELUX UNION SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 105 BENELUX UNION SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 106 BELGIUM SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 107 BELGIUM SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 108 BELGIUM SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 109 BELGIUM SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 110 BELGIUM SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 111 NETHERLANDS SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 112 NETHERLANDS SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 113 NETHERLANDS SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 114 NETHERLANDS SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 115 NETHERLANDS SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 116 LUXEMBOURG SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 117 LUXEMBOURG SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 118 LUXEMBOURG SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 119 LUXEMBOURG SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 120 LUXEMBOURG SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 121 ITALY SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 122 ITALY SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 123 ITALY SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 124 ITALY SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 125 ITALY SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 126 SPAIN SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 127 SPAIN SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 128 SPAIN SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 129 SPAIN SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 130 SPAIN SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 131 SWITZERLAND SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 132 SWITZERLAND SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 133 SWITZERLAND SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 134 SWITZERLAND SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 135 SWITZERLAND SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 136 REST OF WESTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 137 REST OF WESTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 138 REST OF WESTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 139 REST OF WESTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 140 REST OF WESTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 141 EASTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 142 EASTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 143 EASTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 144 EASTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 145 EASTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 146 ASIA PACIFIC SLEEPING BRUXISM TREATMENT MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 147 ASIA PACIFIC SLEEPING BRUXISM TREATMENT MARKET SHARE BY REGION 2017 (%)

TABLE 148 ASIA PACIFIC SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 149 ASIA PACIFIC SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 150 ASIA PACIFIC SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 151 ASIA PACIFIC SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 152 ASIA PACIFIC SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 153 CHINA SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 154 CHINA SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 155 CHINA SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 156 CHINA SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 157 CHINA SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 158 INDIA SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 159 INDIA SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 160 INDIA SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 161 INDIA SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 162 INDIA SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 163 JAPAN SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 164 JAPAN SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 165 JAPAN SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 166 JAPAN SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 167 JAPAN SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 168 SOUTH KOREA SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 169 SOUTH KOREA SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 170 SOUTH KOREA SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 171 SOUTH KOREA SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 172 SOUTH KOREA SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 173 REST OF ASIA PACIFIC SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 174 REST OF ASIA PACIFIC SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 175 REST OF ASIA PACIFIC SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 176 REST OF ASIA PACIFIC SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 177 REST OF ASIA PACIFIC SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 178 MIDDLE EAST & AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY REGION 2015-2023 (USD MILLION)

TABLE 179 MIDDLE EAST & AFRICA SLEEPING BRUXISM TREATMENT MARKET SHARE BY REGION 2017 (%)

TABLE 180 MIDDLE EAST & AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 181 MIDDLE EAST & AFRICA SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 182 MIDDLE EAST & AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 183 MIDDLE EAST & AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 184 MIDDLE EAST & AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 185 MIDDLE EAST SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 186 MIDDLE EAST SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 187 MIDDLE EAST SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 188 MIDDLE EAST SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 189 MIDDLE EAST SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 190 AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)

TABLE 191 AFRICA SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)

TABLE 192 AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)

TABLE 193 AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)

TABLE 194 AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)

TABLE 195 TOP MANUFACTURERS IN THE GLOBAL SLEEPING BRUXISM TREATMENT MARKET

The key players for the sleeping bruxism treatment market include Randmark Dental Products, LLC, S4S Dental Laboratory, Ipsen Biopharmaceuticals, Inc, Merz Pharma GmbH & Co. KGaA, Carestream Dental, PLANMECA OY, and others.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person